Clinical Outcomes of Robotic Myomectomy
Launched by FAR EASTERN MEMORIAL HOSPITAL · Jan 5, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the outcomes of a surgical procedure called robotic myomectomy, which is used to remove uterine fibroids (also known as myomas) in women. The main goal is to understand what factors can affect how well patients do before, during, and after this surgery. Researchers want to find out if certain characteristics of the patients can predict their recovery and overall results.
To participate in this study, women must be over 20 years old and have already undergone robotic myomectomy. If you join the trial, you can expect to share information about your health and experiences related to the surgery. The study is currently recruiting participants, so if you or someone you know fits the criteria and is interested, it could be a valuable opportunity to contribute to important medical research that may help other women in the future.
Gender
FEMALE
Eligibility criteria
- • Inclusion criteria
- • \>20 years old women
- • women who received robotic myomectomy
About Far Eastern Memorial Hospital
Far Eastern Memorial Hospital is a leading healthcare institution in Taiwan, renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a focus on multidisciplinary collaboration, the hospital integrates cutting-edge technology and evidence-based practices to conduct rigorous clinical studies across various therapeutic areas. Far Eastern Memorial Hospital prioritizes patient safety and ethical standards, ensuring that all trials are designed to enhance medical knowledge and contribute to the development of new treatments. Its experienced team of researchers and healthcare professionals is dedicated to fostering a research environment that supports scientific discovery and enhances health outcomes for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Banqiao, New Taipei, Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported